Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Case Report
Author Details :
Volume : 7, Issue : 1, Year : 2021
Article Page : 159-163
https://doi.org/10.18231/j.ijceo.2021.032
Abstract
Iridocorneal endothelial syndrome has three clinical entities- Chandler’s syndrome, progressive iris atrophy and Cogan Reese syndrome. A 40 year old female presented to the department of Ophthalmology with a chief complaint of unusually looking left eye for many years. Ocular examination revealed left eye visual acuity 6/6, Several iris stretch holes at 9 to 12 o’clock, with marked iris thinning. Pupil had polycoria and corectopia. Fundus examination revealed normal disc with 0.5cup disk ratio, IOP -24mm Hg. OCT RNLF and visual fields were normal. RE was completely within normal limits. Patient was started on eye drop Timolol 0.5%, 1 drop BD in left eye. On follow up the IOP was under control (18 mm Hg). Since patient had predominant progressive changes in the iris and specific unilateral clinical features, it was diagnosed as essential iris atrophy with early secondary glaucomatous features.
Keywords: Progressive iris, Secondary glaucoma.
How to cite : Kumar M S , Gnanadurai J S C , Huda R , ICE syndrome- Progressive iris atrophy with secondary glaucoma. Indian J Clin Exp Ophthalmol 2021;7(1):159-163
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
